An Epidemiological Study Aimed to Record Standard Daily Practice in Managing Patients With Hypercholesterolemia

Completed

• Conditions: Hypercholesterolemia

• Registration Number: NCT01206231
• Lead Sponsor: AstraZeneca

Brief Summary

This study is aimed to collect the following Serbia-specific epidemiology data on hypercholesterolemia: patents characteristics, patients' management/treatment and physicians' standard practice. In addition, the aim is to determine the proportion of patients on lipid-lowering pharmacological treatment who have reached the LDL-C and HDL-C treatment goals.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2010-09-20
• Study First Submitted QC: 2010-09-20
• Study First Posted: 2010-09-21
• Study Start: 2010-12
• Primary Completion: 2011-10
• Study Completion: 2011-10
• Status Verified: 2011-11
• Last Update Submitted: 2011-11-07
• Last Update Posted: 2011-11-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 330

Inclusion Criteria

• Patients with hypercholesterolemia currently receiving a lipid lowering agent

Exclusion Criteria

• Pregnancy and lactation.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the NCEP ATP III / updated 2004 NCEP ATP III guidelines	24 weeks

Secondary Outcome Measures

Name	Time	Method
Proportion of patients on lipid-lowering pharmacological treatment reaching the non HDL-C goals according to the NCEP ATP III / updated 2004 NCEP ATP III guidelines;	24 weeks
Physicians' standard practice in managing patients with hypercholesterolemia (by using physicians' questionnaire);	24 weeks
Local epidemiological date on patients with hypercholesterolemia (Demographic Data; Hypercholesterolemia management data: treatment, treatment changes)	24 weeks

Trial Locations

Locations (1)

Research Site; 🇷🇸 Uzice, Serbia